# Education, work and the years that were interrupted

Source: https://onco.cc/technologies/rejuv-ayac-education-and-work/  
OnCo record `rejuv-ayac-education-and-work` (Technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Cancer in the years when education and first jobs happen costs more than the time taken. In the largest cohort, 23 per cent of childhood cancer survivors had used special education services against 8 per cent of siblings, and survivors of several cancers were less likely to finish high school. The important finding is that where the educational support was given, the gap closed.

## Summary

The evidence on schooling comes from 12,430 survivors and 3,410 siblings in the Childhood Cancer Survivor Study. The use of special education services was reported by 23 per cent of survivors against 8 per cent of siblings, with the greatest differences among survivors diagnosed before the age of six: central nervous system tumours (odds ratio 18.8, 95 per cent confidence interval 15.01 to 23.49), leukaemia (4.4, 3.75 to 5.16) and Hodgkin disease (4.4, 2.64 to 7.24). Treatment mattered in a dose-dependent way: cranial radiation alone carried an odds ratio of 7.2 (6.14 to 8.39), intrathecal methotrexate alone 1.3 (1.09 to 1.78), and the two combined 2.6 (2.30 to 2.95), with a positive dose response for higher cranial radiation doses. Survivors of leukaemia (1.6), central nervous system tumours (2.7), non-Hodgkin lymphoma (1.8) and neuroblastoma (1.7) were significantly less likely than siblings to finish high school.

Then the finding that matters most: "when survivors received SE services, risk estimates approximated those of the sibling SE population". Among children who needed educational support and got it, survivors did about as well as siblings who needed it. The support worked. The authors' recommendation follows directly: children with cancer "should be followed closely during and after treatment to identify early signs of learning disabilities and to maximize intervention strategies for the successful completion of scholastic goals". Neurocognitive screening is therefore not an academic exercise; it is the trigger for the one intervention with evidence of closing the gap.

Work is the sequel. The St Jude Lifetime Cohort found that neurocognitive impairment in adult survivors of childhood leukaemia "was associated with reduced educational attainment and unemployment", which links the two directly: the mechanism running from cranial radiotherapy to a lower income in adulthood is measurable at each step. Employment and insurance are listed among the three central vulnerabilities of the adolescent and young adult population, along with trial enrolment and psychosocial support, and the International Guideline Harmonization Group has published recommendations on education and employment outcomes.

What a reader can do. Ask for formal neurocognitive assessment rather than a general reassurance, because an assessment is what unlocks support in most school systems. Ask for the assessment to be repeated, because the deficit widens with age as the age-expected norm rises and a child who tested normal at eight may not test normal at thirteen. In work, the relevant protections in the United Kingdom come from disability legislation and reasonable adjustments rather than from anything cancer-specific, and a late effect such as fatigue or impaired processing speed can qualify.

What comes back, and when: time out of education is made up more often than people fear, with support. What is not recovered without intervention is the processing speed that makes learning feel harder, and the practical approach is accommodation rather than cure: more time, written instructions, a quiet room, and a plan that is reviewed as the child grows.

## Fields

- Kind: Technology
- Status: established
- Last checked: 2026-10-02
- Tags: rejuvenation; survivorship; paediatric; late-effects; evidence:moderate
- Principle: Reduced processing speed and working memory raise the effort required for every academic task without lowering the ceiling of what can be understood, so performance falls behind in timed and high-load settings and recovers when the load is adjusted. Educational support works because it changes the load rather than the deficit, and its effect was large enough in the cohort data to bring survivors who received it to the level of siblings who received it.
- Strengths: Educational support measurably closed the attainment gap; The causal chain from exposure to attainment to employment is traceable in cohort data; Assessment is the trigger for support and is available in most school systems
- Limitations: The attainment data are self-reported and describe treatments given decades ago; Support depends on a formal assessment that is often not arranged; No cancer-specific employment protection; survivors rely on general disability provisions

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/Cancer_survivor
- Utilization of special education services and educational attainment among long-term survivors of childhood cancer (CCSS) (Cancer 2003): https://doi.org/10.1002/cncr.11117
- Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukaemia (SJLIFE) (JCO 2013): https://doi.org/10.1200/JCO.2012.48.2315
- Adolescent and young adult oncology: past, present and future (CA Cancer J Clin 2019): https://doi.org/10.3322/caac.21585
- International Guideline Harmonization Group: published and in-development guidelines: https://www.ighg.org/guidelines/

## Connected records

- trials: [Childhood Cancer Survivor Study (CCSS)](https://onco.cc/trials/ccss/)
- collections: [International Guideline Harmonization Group for late effects of childhood cancer](https://onco.cc/collections/ighg/), [St Jude Lifetime Cohort Study (SJLIFE)](https://onco.cc/collections/sjlife/)
- cancers: [Acute lymphoblastic leukaemia](https://onco.cc/cancers/all-leukemia/), [Childhood cancers (all types)](https://onco.cc/cancers/childhood-cancers/), [Hodgkin lymphoma](https://onco.cc/cancers/hodgkin-lymphoma/), [Medulloblastoma](https://onco.cc/cancers/medulloblastoma/), [Neuroblastoma (paediatric)](https://onco.cc/cancers/neuroblastoma/), [Paediatric low-grade glioma](https://onco.cc/cancers/paediatric-low-grade-glioma/)
- fronts: [Recovery & Rejuvenation](https://onco.cc/fronts/rejuvenation/), [Supportive Care & Survivorship](https://onco.cc/fronts/supportive-care/)
- technologies: [Adolescents and young adults: a group with its own cancers, its own gap and its own needs](https://onco.cc/technologies/rejuv-ayac-distinct-group/), [Memory, attention and learning after treatment of a childhood cancer](https://onco.cc/technologies/rejuv-paed-neurocognitive/), [Services built for teenagers and young adults, and what the national evaluation found](https://onco.cc/technologies/rejuv-ayac-services/), [Survivorship care and late-effects surveillance](https://onco.cc/technologies/survivorship-care-plan/), [Thinking and memory after cancer treatment: what is measurable, and what helps](https://onco.cc/technologies/cognitive-impairment-after-cancer-treatment/)
- drugs: [Methotrexate](https://onco.cc/drugs/methotrexate/)
- terms: [Late effects and survivorship toxicity](https://onco.cc/terms/late-effects/), [Quality of life](https://onco.cc/terms/quality-of-life/)
- bottlenecks: [Survivorship and late effects are neglected](https://onco.cc/bottlenecks/b-survivorship/), [Toxicity and quality of life are undervalued](https://onco.cc/bottlenecks/b-toxicity-qol/)

---
JSON: https://onco.cc/api/v1/entities/rejuv-ayac-education-and-work.json